Mirexia XR 25mg Tablets (20s)

Product Overview

Mirexia Xr 25mg Tablets are a prescription medication used to treat overactive bladder (OAB) symptoms, such as frequent urination, urgency, and urinary incontinence. This medication belongs to a class of drugs known as beta-3 adrenergic agonists, which work by relaxing the bladder muscles to improve bladder control.

Key Benefits

Reduces the frequency of urination

- Decreases the urgency to urinate

- Helps control episodes of urinary incontinence

- Improves overall bladder function

- Extended-release formula for long-lasting relief

How It Works

The active ingredient in Mirexia Xr 25mg Tablets is Mirabegron, which acts on beta-3 adrenergic receptors in the bladder muscle. By activating these receptors, Mirabegron relaxes the bladder muscle, increasing its capacity to hold urine and reducing the urge to urinate. This mechanism helps to improve bladder control and reduce OAB symptoms.

Storage Instructions

Store Mirexia Xr 25mg Tablets at room temperature away from moisture and heat. Keep it out of reach of children and pets. Do not use the medication after the expiration date printed on the packaging.

Precautions

Take Mirexia Xr 25mg Tablets as prescribed by your healthcare provider. Swallow the tablet whole with a glass of water, do not crush or chew it. It is usually taken once daily with or without food. Follow your doctor's instructions carefully for the best results.

Inform your doctor about any medical conditions or allergies before taking Mirexia Xr 25mg Tablets.

- Avoid consuming alcohol while taking this medication as it may worsen side effects.

- Do not drive or operate heavy machinery until you know how this medication affects you.

- Contact your doctor if you experience severe side effects or allergic reactions.

Manufacturer Information

Mirexia Xr 25mg Tablets are manufactured by Ferozsons, a reputable pharmaceutical company known for producing high-quality medications. For more information about the product or the company, visit www.ferozsons.com.